Baader Bank Aktiengesellschaft’s Applied Therapeutics APLT Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13,700	Closed	-$2.63K	–	496
2025 Q2	$2.63K	Buy	+13,700	New	+$5.3K	﹤0.01%	437

Other funds holding APLT

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Baader Bank Aktiengesellschaft's APLT Position: Q3 2025 in Review

Baader Bank Aktiengesellschaft sold out of Applied Therapeutics (APLT) in Q3 2025, closing a stake of 13,700 shares — an estimated $2.63K sold.

Baader Bank Aktiengesellschaft first reported a position in APLT in Q2 2025 and held it in 1 quarter. The position peaked at $2.63K in Q2 2025. 70 funds tracked by Wall St. Rank hold APLT as of Q3 2025.

Baader Bank Aktiengesellschaft reported no remaining Applied Therapeutics position as of Q3 2025 after selling out during the quarter.
Baader Bank Aktiengesellschaft sold 13,700 Applied Therapeutics shares in Q3 2025, an estimated $2.63K.
Baader Bank Aktiengesellschaft first reported a position in Applied Therapeutics in Q2 2025 and held it in 1 quarter.
Baader Bank Aktiengesellschaft's Applied Therapeutics position peaked at $2.63K in Q2 2025.
70 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2025.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q3 2025, filed 6 Nov 2025.